Juhan-Vague I - Search Results

1

Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome.

Aubert H, Frère C, Aillaud MF, Morange PE, Juhan-Vague I, Alessi MC. Aubert H, et al. J Thromb Haemost. 2003 Apr;1(4):791-7. doi: 10.1046/j.1538-7836.2003.00147.x. J Thromb Haemost. 2003. PMID: 12871417 Free article.

2

Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M, Juhan-Vague I, Alessi MC. Bastelica D, et al. Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):173-8. doi: 10.1161/hq0102.101552. Arterioscler Thromb Vasc Biol. 2002. PMID: 11788479

3

Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence. The PRIME Study (Prospective Epidemiological Study of MI).

Morange PE, Juhan-Vague I, Scarabin PY, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P; PRIME Study group. Morange PE, et al. Thromb Haemost. 2003 Mar;89(3):554-60. Thromb Haemost. 2003. PMID: 12624641

4

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.

Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I. Alessi MC, et al. Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1262-8. doi: 10.1161/01.ATV.0000077401.36885.BB. Epub 2003 May 15. Arterioscler Thromb Vasc Biol. 2003. PMID: 12750120

5

The insulin resistance syndrome: implications for thrombosis and cardiovascular disease.

Juhan-Vague I, Morange PE, Alessi MC. Juhan-Vague I, et al. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):269-73. doi: 10.1159/000073579. Pathophysiol Haemost Thromb. 2002. PMID: 13679655 Review.

6

Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact.

Frère C, Morange PE, Saut N, Tregouet DA, Grosley M, Beltran J, Juhan-Vague I, Alessi MC. Frère C, et al. Thromb Haemost. 2005 Aug;94(2):373-9. doi: 10.1160/TH04-08-0497. Thromb Haemost. 2005. PMID: 16113828

7

PAI-1 and the metabolic syndrome: links, causes, and consequences.

Alessi MC, Juhan-Vague I. Alessi MC, et al. Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2200-7. doi: 10.1161/01.ATV.0000242905.41404.68. Epub 2006 Aug 24. Arterioscler Thromb Vasc Biol. 2006. PMID: 16931789 Review.

8

Polymorphism A36G of the tumor necrosis factor receptor 1 gene is associated with PAI-1 levels in obese women.

Mavri A, Bastelica D, Poggi M, Morange P, Peiretti F, Verdier M, Juhan-Vague I, Alessi MC. Mavri A, et al. Thromb Haemost. 2007 Jan;97(1):62-6. Thromb Haemost. 2007. PMID: 17200772

9

Metabolic syndrome, haemostasis and thrombosis.

Alessi MC, Juhan-Vague I. Alessi MC, et al. Thromb Haemost. 2008 Jun;99(6):995-1000. doi: 10.1160/TH07-11-0682. Thromb Haemost. 2008. PMID: 18521499 Review.

10

Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective cohort.

Alessi MC, Nicaud V, Scroyen I, Lange C, Saut N, Fumeron F, Marre M, Lantieri O, Fontaine-Bisson B, Juhan-Vague I, Balkau B, Tregouet DA, Morange PE; DESIR Study Group. Alessi MC, et al. Among authors: juhan vague i. Thromb Haemost. 2011 Sep;106(3):416-22. doi: 10.1160/TH11-03-0179. Epub 2011 Jul 28. Thromb Haemost. 2011. PMID: 21800006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters